Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of allelic loss at TP53 in endometrial carcinomas.

Oncology - 1 Jan 2010

Semczuk Andrzej, Schneider-Stock Regine, Szewczuk Wiktor

Abstract excerpt

Alterations within the TP53 tumor suppressor belong to the most common genetic features reported in various human neoplasms, including endometrial cancer. In this article, the prevalence of allelic loss at the TP53 locus in primary human endometrial carcinomas (ECs) is discussed. Furthermore, we reviewed the role of allelic imbalance at 17p13.1 in metastatic human ECs on the basis of a literature review and on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Chromosomes, Human, Pair 17
Share to Codon

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Loss of Heterozygosity

Share to Neoplasm Metastasis

Source

Identifiers

PMID: 20453538
DOI: 10.1159/000314353

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of allelic loss at TP53 in endometrial carcinomas.PMID 20453538Read ↗

Allelic loss at TP53 in metastatic human endometrial carcinomas.Semantic proximity Read ↗

Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.Semantic proximity Read ↗

Involvement of p53 gene mutations in human endometrial carcinomas.Semantic proximity Read ↗

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients.Semantic proximity Read ↗

Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.Semantic proximity Read ↗

Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer.Semantic proximity Read ↗

TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.Semantic proximity Read ↗

Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.Semantic proximity Read ↗

A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.Semantic proximity Read ↗

TP73 alterations in cervical carcinoma.Semantic proximity Read ↗

p53 gene mutations in human endometrial carcinoma.Semantic proximity Read ↗

Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.